<DOC>
	<DOCNO>NCT02154178</DOCNO>
	<brief_summary>The investigator hypothesize use biomarkers invasive fungal infection would increase percentage early discontinuation empirical antifungal therapy thus reduce duration treatment ICU patient .</brief_summary>
	<brief_title>Fungal Biomarkers Reduce Duration Empirical Antifungal Therapy : Randomized Comparative Study ( STAFE )</brief_title>
	<detailed_description>The duration empirical/preemptive anti fungal treatment base intervention group biomarker result . Biomarkers fungal disease perform start anti fungal treatment day 4 .</detailed_description>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>Age &gt; = 18 year Patients require empiric antifungal therapy first time ICU Predictable duration hospitalization ICU â‰¥ 6 day Neutropenia ( WBC &lt; 1000 neutrophils &lt; 500/mm3 ) Immunosuppressive therapy ( chemotherapy within 3 month prior ICU admission , solid organ graft immunosuppressive therapy ) invasive fungal infection document three previous month Antifungal treatment three previous month Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>empiric antifungal therapy</keyword>
	<keyword>biomarkers</keyword>
	<keyword>invasive fungal infection</keyword>
	<keyword>Candida</keyword>
</DOC>